Retinoblastoma protein is the likely common effector for distinct anti-aging pathways

Details Retinoblastoma protein is the likely common effector for distinct anti-aging pathways Retinoblastoma protein is the likely common effector for distinct anti-aging pathways

2007-07-27

arxiv.org/abs/0707.4174v1

Biology

Quantitative Biology

Subcellular Processes

4 pages

Scientific paper

The multiple worlds of genetically manipulated laboratory organisms such as transgenic mice or worms with certain gene mutations are somewhat reminiscent of parallel worlds in quantum mechanics. So are various models of aging tested in such organisms. In this context, the tumor suppressor p53 has been found to either accelerate or delay aging, the latter, for instance, in conjunction with ARF, another tumor suppressor, as shown very recently. To more easily determine which of these artificial settings comes closest to real life, I discuss here their features in the light of my protein structure-based insights that have led me to propose a physiological anti-aging role for the retinoblastoma tumor suppressor protein (RB) over the past four years.

Affiliated with

Also associated with

No associations

Rating

Retinoblastoma protein is the likely common effector for distinct anti-aging pathways does not yet have a rating. At this time, there are no reviews or comments for this scientific paper.

If you have personal experience with Retinoblastoma protein is the likely common effector for distinct anti-aging pathways, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Retinoblastoma protein is the likely common effector for distinct anti-aging pathways will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFWR-SCP-O-395522